Dr. Sherry Dunbar is a distinguished scientific executive, accomplished researcher, and influential leader with approximately 40 years of experience advancing medical microbiology, molecular diagnostics, biotechnology, immunology, and infectious disease research. Throughout her career, she has demonstrated an unwavering commitment to scientific excellence, technological innovation, and improving healthcare outcomes through the development and application of advanced diagnostic solutions. Combining extensive scientific expertise with executive leadership and business acumen, Dr. Dunbar brings a valuable perspective to organizations navigating the evolving complexities of healthcare, laboratory medicine, and life sciences. Her professional journey reflects a dedication to translating scientific discoveries into practical applications that strengthen diagnostic capabilities, support healthcare professionals, and contribute to meaningful advancements in patient care.
Currently serving as Senior Director of Scientific Affairs Programs at Diasorin in Austin, Texas, Dr. Dunbar plays an important leadership role within an organization recognized for its contributions to diagnostic technologies and laboratory solutions. Since assuming this position in 2022, she has continued building upon her extensive experience in scientific affairs, research, and the diagnostics industry. Her responsibilities place her at the intersection of scientific knowledge, industry collaboration, and strategic communication, where her expertise helps connect technological capabilities with the evolving needs of the clinical laboratory community. Her leadership reflects an understanding that successful scientific innovation requires not only technical excellence but also collaboration, adaptability, and the ability to communicate complex information effectively to diverse professional audiences.
Before joining Diasorin in her current capacity, Dr. Dunbar established an extensive leadership career at Luminex Corporation, where she served in progressively influential scientific and executive positions over more than two decades. Beginning as a Staff Scientist in Biology Research and Development in 1999, she advanced through technical applications and research leadership roles, including Director of Technical Applications, Senior Director of Technical Applications, and Senior Director of Biology Research and Development. Her progression into Director of Scientific Affairs and subsequently Senior Director of Global Scientific Affairs reflected the breadth of her scientific expertise and her ability to contribute across multiple organizational functions. These experiences provided her with a comprehensive understanding of the scientific, technical, and organizational considerations involved in developing and supporting sophisticated diagnostic technologies.
During her tenure at Luminex, Dr. Dunbar developed particular expertise in multiplex molecular diagnostic technologies, microsphere-based suspension arrays, immunoassays, and methods for detecting infectious pathogens. Her scientific contributions have addressed applications involving respiratory infections, bloodstream infections, gastrointestinal pathogens, genetic testing, and other important areas of laboratory medicine. Her work has helped advance the scientific understanding and evaluation of technologies designed to identify multiple biological targets efficiently and accurately. Through her involvement in research, technical applications, and scientific affairs, she has developed a perspective that connects laboratory innovation with clinical utility, scientific evidence, and the practical demands of healthcare environments.
Dr. Dunbar’s foundation in clinical laboratory medicine began well before her executive leadership career. She served as Laboratory Director at Virus Reference Laboratory in Houston, Texas, following advanced postdoctoral training in clinical and public health microbiology at Baylor College of Medicine. Her early professional experiences provided valuable exposure to clinical diagnostic practices, infectious disease testing, laboratory operations, and the scientific challenges encountered in medical microbiology. This combination of hands-on laboratory experience and advanced research training continues to distinguish her professional perspective. She understands diagnostic technologies not merely as scientific innovations but as essential tools that support clinical decision-making, disease identification, and public health.
A committed lifelong learner, Dr. Dunbar has complemented her scientific accomplishments with a strong academic foundation and formal business education. She earned her Bachelor of Science in Microbiology from the University of Maryland in 1986, followed by a Doctor of Philosophy in Medical Microbiology and Immunology from the University of South Alabama College of Medicine in 1995. She subsequently completed postdoctoral fellowships at the University of South Alabama and Baylor College of Medicine, further strengthening her expertise in clinical and public health microbiology. Recognizing the importance of integrating scientific leadership with broader organizational and business considerations, she earned her Master of Business Administration from the University of Maryland’s Robert H. Smith School of Business in 2017. This combination of advanced scientific education and business training equips her to evaluate complex opportunities through both technical and commercial lenses.
Beyond her corporate leadership responsibilities, Dr. Dunbar has established a substantial record of scientific scholarship and industry contribution. Her curriculum vitae documents 58 publications spanning original research, scientific reviews, book chapters, and other scholarly contributions. Her published work addresses a broad spectrum of subjects, including molecular diagnostic methods, multiplexed pathogen detection, respiratory infections, bloodstream infections, vaccine-related immunoassays, and diagnostic responses to the COVID-19 pandemic. She is also a named inventor on a European patent concerning methods for controlling reagent reactivity in immunoassays. These achievements reflect her sustained engagement in scientific discovery and her ability to contribute knowledge that extends beyond the organizations in which she has served.
Dr. Dunbar’s professional influence is further demonstrated through her involvement in scientific standards development and respected editorial organizations. She has held numerous responsibilities with the Clinical and Laboratory Standards Institute, including participation in expert panels, document development committees, and initiatives addressing molecular diagnostic methods and laboratory practices. In 2023, she received the organization’s Excellence in Standards Development Award, recognizing her contributions to this important area of laboratory science. Since 2024, she has served as Chairholder of its Expert Panel for Molecular Methods, following earlier service as Vice Chairholder. Her leadership in these activities demonstrates a commitment to scientific rigor, quality, consistency, and the responsible application of diagnostic technologies.
Her contributions to scientific publishing further reinforce her reputation as an engaged and respected professional within the microbiology community. Dr. Dunbar serves on the Editorial Board of the Journal of Clinical Microbiology and as an Associate Editor for Clinical Microbiology with Frontiers in Cellular and Infection Microbiology. She has also contributed editorial expertise to scientific collections addressing pandemic preparedness and multiplexed technologies for vaccine research. These responsibilities require critical scientific judgment, familiarity with emerging research, and an appreciation for the importance of credible evidence in advancing medical knowledge. Through these activities, she contributes to the broader exchange of ideas that supports continued innovation and professional development across the scientific community.
An experienced presenter and scientific communicator, Dr. Dunbar has participated extensively in professional meetings, conferences, and scientific forums. Her speaking and presentation experience includes engagements associated with the American Society for Microbiology and other prominent medical and scientific organizations. She has communicated research findings and technical insights on subjects ranging from infectious disease detection to molecular diagnostic technologies and laboratory workflow evaluation. Her international professional exposure includes Europe and Asia, contributing to her understanding of the global scientific landscape and the importance of collaboration across geographic and institutional boundaries. Her ability to engage with researchers, laboratory professionals, scientific organizations, and industry stakeholders strengthens her effectiveness as both a technical authority and an executive leader.
Throughout her professional journey, Dr. Dunbar has maintained active relationships with organizations that help shape the future of microbiology and laboratory medicine. Her professional affiliations have included the American Society for Microbiology, Association for Molecular Pathology, Clinical and Laboratory Standards Institute, Pan-American Society for Clinical Virology, and Infectious Diseases Society of America. These connections reflect her sustained involvement in the scientific community and provide opportunities to remain informed about emerging technologies, evolving clinical needs, and developments influencing the diagnostics industry. Her combination of industry experience, scholarly engagement, and professional relationships offers valuable insight into the scientific and operational challenges facing healthcare and biotechnology organizations.
As she considers the next chapter of her career, Dr. Dunbar is particularly interested in applying her experience through corporate board and strategic advisory opportunities. Her interests include medical laboratories, life sciences, biotechnology, research, and diagnostics, while remaining open to evaluating opportunities across additional industries on an individual basis. She recognizes that organizations operating in highly technical and rapidly evolving markets benefit from leadership that can assess scientific innovation, understand industry developments, and connect specialized expertise with broader business priorities. Her background positions her to contribute thoughtful perspectives on technology development, scientific credibility, diagnostic applications, strategic partnerships, and emerging opportunities within healthcare and life sciences.
For Dr. Dunbar, pursuing board service represents a meaningful continuation of a career dedicated to advancing science and making a difference. Rather than stepping away from professional engagement, she is motivated by the opportunity to remain active, share her accumulated knowledge, and contribute to organizations working toward meaningful scientific and healthcare advancements. Her professional philosophy is grounded in the belief that experience becomes most valuable when it is used to guide others, encourage innovation, and support decisions that create lasting positive impact. With her extensive scientific background, demonstrated executive progression, business education, and commitment to professional service, Dr. Dunbar offers prospective boards and advisory teams a compelling combination of knowledge, perspective, and purpose. She approaches this next chapter with the same curiosity, dedication, and commitment to excellence that have defined her distinguished career.
Character:
Dr. Dunbar demonstrates integrity, dedication, and a sustained commitment to advancing scientific knowledge and improving healthcare through meaningful professional contributions. Her willingness to share her experience, support industry standards, and remain actively involved in scientific leadership reflects a service-oriented mindset and a strong sense of professional responsibility.
Knowledge:
With approximately four decades of experience in microbiology, molecular biology, immunology, infectious diseases, and diagnostics, Dr. Dunbar possesses exceptional technical depth supported by extensive research, publications, and executive experience. Her PhD, MBA, scientific editorial responsibilities, and leadership in laboratory standards development provide a multidisciplinary foundation for evaluating complex scientific and business challenges.
Strategic:
Dr. Dunbar combines advanced scientific expertise with business education and experience leading research, technical applications, and global scientific affairs functions. Her understanding of diagnostic innovation, industry developments, clinical laboratory needs, and organizational priorities enables her to contribute informed perspectives to strategic planning, technology evaluation, and long-term organizational growth.
Communication:
An accomplished scientific communicator whose extensive publication record, editorial appointments, and professional speaking engagements demonstrate her ability to convey sophisticated scientific concepts with clarity and authority. Her experience collaborating across scientific disciplines, professional organizations, and international environments supports productive dialogue, informed decision-making, and effective engagement with diverse stakeholders.


